Pseudomonas aeruginosa and cystic fibrosis:: first colonization to chronic infection

被引:0
|
作者
Laurans, M.
Arion, A.
Fines-Guyon, M.
Regeasse, A.
Brouard, J.
Leclercq, R.
Duhamel, J. F.
机构
[1] Serv Pediat, F-14033 Caen 05, France
[2] Microbiol Serv, F-14033 Caen, France
[3] Serv Informat CRCM Caen, F-14033 Caen 05, France
来源
ARCHIVES DE PEDIATRIE | 2006年 / 13卷
关键词
Pseudomonas aeruginosa; cystic fibrosis;
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Pseudomonas aeruginosa (Pa) is the most common virulent respiratory pathogen in cystic fibrosis and is characterized by an important capacity of adaptation, adherence and communication. The factors of virulence of Pa play a major part in adherence with the respiratory epithelial cells and in occurrence of infectious episodes. The factors responsible for the transition of first Pa acquisition to the chronic infection are not elucidated yet. The system of secretion of type III and the quorum sensing (QS) play an important role. The QS would intervene in the maturation of the biofilm of Pa, responsible for the "mucoid" phenotype of Pa, associated to a degradation of the respiratory function. We made a retrospective study on the period 1984-2005 within the Center of Cystic fibrosis of Caen allow to determine the percentage of firstly-colonized and chronic infected patients with Pa according to age. At 6 months of life, 11% of the infants were colonized with Pa reaching 48% to 7 years and 85% at the 18 years age. The percentage of chronic children carrying Pa was 0% at 1 year, 11% at 4 years, 44% at 12 years and 74% at 18 years according to the method of Kaplan-Meier. Comparing the period 1984-1994 with that of 1995-2005, the firstly-colonization and the chronic carrying of Pa occurred earlier and significantly during the second period. The current objective, beside the respiratory care, comprises the maintenance of an optimal nutritional statute and, waiting for an effective vaccine, the development of new therapeutic targets in order to attenuate the virulence of the stocks of Pa and as much as possible to delay the age of firstly-colonization and the age of chronic colonization with mucoid Pa. (c) 2006 Elsevier SAS. Tous droits reserves.
引用
收藏
页码:S22 / S29
页数:8
相关论文
共 50 条
  • [31] Conditions Associated with the Cystic Fibrosis Defect Promote Chronic Pseudomonas aeruginosa Infection
    Staudinger, Benjamin J.
    Muller, Jocelyn Fraga
    Halldorsson, Skarpheoinn
    Boles, Blaise
    Angermeyer, Angus
    Dao Nguyen
    Rosen, Henry
    Baldursson, Olafur
    Gottfreosson, Magnus
    Guomundsson, Guomundur Hrafn
    Singh, Pradeep K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189 (07) : 812 - 824
  • [32] CO-REGULATION OF PSEUDOMONAS AERUGINOSA POLYSACCHARIDES IN CHRONIC CYSTIC FIBROSIS INFECTION
    Cross, A. R.
    Goldberg, J. B.
    PEDIATRIC PULMONOLOGY, 2018, 53 : 276 - 276
  • [33] PSEUDOMONAS-AERUGINOSA, MUCOIDY AND THE CHRONIC INFECTION PHENOTYPE IN CYSTIC-FIBROSIS
    DERETIC, V
    SCHURR, MJ
    YU, HW
    TRENDS IN MICROBIOLOGY, 1995, 3 (09) : 351 - 356
  • [34] DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis
    Viel, Marion
    Hubert, Dominique
    Burgel, Pierre-Regis
    Genin, Emmanuelle
    Honore, Isabelle
    Martinez, Brigitte
    Gaitch, Natacha
    Chapron, Jeanne
    Kanaan, Reem
    Dusser, Daniel
    Girodon, Emmanuelle
    Bienvenu, Thierry
    CLINICAL RESPIRATORY JOURNAL, 2016, 10 (06): : 777 - 783
  • [35] Management of chronic Pseudomonas aeruginosa infection with inhaled levofloxacin in people with cystic fibrosis
    Elborn, J. Stuart
    Flume, Patrick A.
    Van Devanter, Donald R.
    Procaccianti, Claudio
    FUTURE MICROBIOLOGY, 2021, 16 (14) : 1087 - 1104
  • [36] Once-weekly azithromycin in cystic fibrosis with chronic Pseudomonas aeruginosa infection
    Steinkamp, Gratiana
    Schmitt-Grohe, Sabina
    Doering, Gerd
    Staab, Doris
    Pfruender, Dietmar
    Beck, Gudrun
    Schubert, Ralf
    Zielen, Stefan
    RESPIRATORY MEDICINE, 2008, 102 (11) : 1643 - 1653
  • [37] Vaccines for preventing infection with Pseudomonas aeruginosa in cystic fibrosis
    Johansen, Helle Krogh
    Gotzsche, Peter C.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (04):
  • [38] Pseudomonas aeruginosa cross-infection in cystic fibrosis
    Jones, AM
    Webb, AK
    Govan, JRW
    Hart, CA
    Walshaw, MJ
    LANCET, 2002, 359 (9305): : 527 - 527
  • [39] Cystic fibrosis lung environment and Pseudomonas aeruginosa infection
    Bhagirath, Anjali Y.
    Li, Yanqi
    Somayajula, Deepti
    Dadashi, Maryam
    Badr, Sara
    Duan, Kangmin
    BMC PULMONARY MEDICINE, 2016, 16
  • [40] Vaccines for preventing infection with Pseudomonas aeruginosa in cystic fibrosis
    Johansen, Helle Krogh
    Gotzsche, Peter C.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (08):